TrialCancer immunology, immunotherapy : CII2012

Metronomic cyclophosphamide treatment in metastasized breast cancer patients: immunological effects and clinical outcome.

Yingzi Ge et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.